The Journal of Immunology, Vol 159, Issue 7 3383-3390, Copyright © 1997 by American Association of Immunologists

ARTICLES

Position-dependent variegation of a CD4 minigene with targeted expression to mature CD4+ T cells

O Boyer, JC Zhao, JL Cohen, D Depetris, M Yagello, L Lejeune, S Bruel, MG Mattei and D Klatzmann
Laboratoire de Biologie et Therapeutique des Pathologies Immunitaires, Centre National de la Recherche Scientifique ERS 107, Groupe Hospitalier Pitie-Salpetriere, Paris, France.

The CD4 gene follows a complex and highly regulated pattern of expression throughout T cell development. This expression is governed by different regulatory elements that have been partly identified, including a promoter, a proximal enhancer, and a silencer. Here we show that a CD4 minigene comprising a combination of these elements is specifically expressed in mature CD4+ T cells of transgenic mice, but not in CD4+CD8+ double positive thymocytes. The proportion of transgene- expressing CD4+ T cells was constant within a given transgenic line, but varied greatly from one line to another. We demonstrate that this pattern of expression is due to integration of the transgene within or in the vicinity of centromeric heterochromatin. This position-effect variegation demonstrated with a short CD4 transgene has not been observed with larger ones containing additional regulatory sequences, suggesting that the CD4 gene contains a locus control region. Such position-dependent effects must be taken into consideration when developing transgenic models or gene transfer vectors because they can result in the absence of transgene expression in a subpopulation of target cells. Finally, the combination of the CD4 gene silencer, proximal enhancer, and promoter provides an interesting tool to selectively express genes of interest in mature CD4+ T cells of transgenic mice and for the development of gene therapy vectors.

This article has been cited by other articles:

				B. Sekkali, E. Szabat, E. Ktistaki, M. Tolaini, K. Roderick, N. Harker, A. Patel, K. Williams, T. Norton, and D. Kioussis Human High Mobility Group Box Transcription Factor 1 Affects Thymocyte Development and Transgene Variegation J. Immunol., October 15, 2005; 175(8): 5203 - 5212. [Abstract] [Full Text] [PDF]

				D. M. Tanamachi, D. C. Moniot, D. Cado, S. D. Liu, J. K. Hsia, and D. H. Raulet Genomic Ly49A Transgenes: Basis of Variegated Ly49A Gene Expression and Identification of a Critical Regulatory Element J. Immunol., January 15, 2004; 172(2): 1074 - 1082. [Abstract] [Full Text] [PDF]

				G. Marodon, E. Mouly, E. J. Blair, C. Frisen, F. M. Lemoine, and D. Klatzmann Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene Blood, May 1, 2003; 101(9): 3416 - 3423. [Abstract] [Full Text] [PDF]

				J. L. Cohen, O. Boyer, and D. Klatzmann Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells Blood, October 1, 2001; 98(7): 2071 - 2076. [Abstract] [Full Text] [PDF]

				Z. Hanna, N. Rebai, J. Poudrier, and P. Jolicoeur Distinct regulatory elements are required for faithful expression of human CD4 in T cells, macrophages, and dendritic cells of transgenic mice Blood, October 1, 2001; 98(7): 2275 - 2278. [Abstract] [Full Text] [PDF]

				R. K. Tripathi, N. Mathieu, S. Spicuglia, D. Payet, C. Verthuy, G. Bouvier, D. Depetris, M.-G. Mattei, W. M. HempeL, and P. Ferrier Definition of a T-Cell Receptor beta Gene Core Enhancer of V(D)J Recombination by Transgenic Mapping Mol. Cell. Biol., January 1, 2000; 20(1): 42 - 53. [Abstract] [Full Text]